杜比基酸酶在调节癌症化学抵抗中的新兴作用
Sukeerthi Dasharathy1, Pranay1, Santhosh K Devadas2
1Department of Biotechnology, Faculty of Life and Allied Health Sciences, M.S. Ramaiah University of Applied Sciences, Bangalore 560054, India.
Drug discovery today
|March 21, 2025
概括
脱基酶 (DUBs) 酶在癌症化学抵抗中发挥着关键作用. 抑制DUB是一种有希望的策略,可以克服耐药性并改善癌症治疗结果.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 化疗是癌症治疗的基石,但化疗抵抗经常导致治疗失败.
- 脱基酶 (DUBs) 是参与蛋白质调节的酶,并且已成为化学抵抗中的关键参与者.
- DUBs可以根据其特定的蛋白质标促进或抑制治疗耐药性.
研究的目的:
- 审查DUBs在各种癌症类型中促进化学抵抗的多种机制.
- 探索DUB抑制剂在克服化学抵抗方面的治疗潜力.
- 突出涉及DUB抑制剂的组合疗法的承诺,以改善癌症治疗.
主要方法:
- 对研究DUB和化学抵抗的研究的文献综述.
- 对DUB参与多种癌症的分析,包括乳腺癌,肺癌,肝癌,胃肠癌,结直肠癌,卵巢癌,前列腺癌和血液癌.
- 对癌症治疗中DUB抑制剂的临床前和临床数据的检查.
主要成果:
- 在广泛的癌症中,DUBs通过各种分子机制与化学抵抗有关.
- 准DUB是一种可行的策略,可以使癌细胞对化疗敏感.
- 临床前研究表明,DUB抑制剂在临床前癌症模型中的有效性.
结论:
- DUBs代表了在瘤学中克服化疗抵抗的重要治疗点.
- DUB 抑制剂有望成为癌症治疗的新型药物.
- 结合DUB抑制剂的组合疗法可以提高治疗效率并改善患者的治疗结果.
相关概念视频
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Covalently Linked Protein Regulators
6.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.7K
Regulated Protein Degradation
7.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.1K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


